SUBSCRIBE
SUBSCRIBE
Genetown

Study Shows Drug Prevents Arthritic Bone Loss

August 17, 2006 | 
1 min read

BOSTON (Reuters) - The Merck and Co. drug Fosamax does a better job at preventing bone deterioration than Vitamin D for people using steroids to treat arthritis, a study showed on Wednesday.>>> Discuss This Story

Merck & Co.
MORE ON THIS TOPIC
Job Trends
Massachusetts’ Life Sciences Job Growth Slows, but 10-Year Outlook Remains Strong: Report
June 12, 2024
 · 
4 min read
 · 
Angela Gabriel
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: Collage of Sarepta Therapeutics, DNA, and an IV bag
FDA
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
May 7, 2024
 · 
4 min read
 · 
Tyler Patchen